Skip to main content
AXTI
NASDAQ Manufacturing

AXT Inc. Finalizes $550M Public Offering at Significant Discount, Diluting Existing Shareholders

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Semiconductor Stocks · Technology
Sentiment info
Negative
Importance info
8
Price
$75.549
Mkt Cap
$4.167B
52W Low
$1.14
52W High
$83.25
52W Position
Off High info
9.2% below high
Rel. Volume info
2.1× avg
Market data snapshot near publication time

AXTI filed a Financing and Capital Events on elevated volume (2.1× avg).

Summary

AXT Inc. has finalized a $550 million public offering of 8.56 million shares at $64.25 each, resulting in significant dilution for existing shareholders and priced at a notable discount to recent market levels.


Key Events · Financing and Capital Events · AXTI

  • Public Offering Finalized

    AXT Inc. is selling 8,560,311 shares of common stock at $64.25 per share, raising approximately $550 million before underwriting discounts and expenses.

  • Significant Shareholder Dilution

    The offering will dilute existing shareholders by approximately 15.4%, increasing to 17.7% if the underwriters exercise their over-allotment option for an additional 1,284,046 shares.

  • Discounted Offering Price

    The shares were priced at $64.25, representing a substantial discount of approximately 18.4% compared to the previous day's closing price of $78.76.

  • Capital for Strategic Growth

    Net proceeds will be used to increase indium phosphide substrate capacity, fund research and development, and for general corporate purposes.


Analysis · AXTI · Manufacturing

This 424B5 filing formalizes the terms of AXT Inc.'s public offering, confirming the sale of 8.56 million shares at $64.25 per share, raising approximately $550 million before expenses. This offering, which represents a substantial 15.4% dilution to existing shareholders (potentially up to 17.7% if the over-allotment option is fully exercised), was priced at a significant discount of approximately 18.4% to the prior day's closing price of $78.76. While the capital infusion is intended to support the expansion of indium phosphide substrate capacity, fund research and development, and for general corporate purposes, the dilutive nature and discounted pricing are likely to be viewed negatively by the market. This filing follows the S-3ASR registration on April 20, 2026, and formalizes the pricing details that were announced in an 8-K on April 21, 2026.

At the time of this filing, AXTI was trading at $75.55 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $4.2B. The 52-week trading range was $1.14 to $83.25. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

AXTI - Latest Insights

AXTI
Jul 08, 2026, 9:29 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $64.15
Real-time Price: $46.50 info
Change: -$17.65 (-28%) info
Market Cap: $3.132B info
AXTI
Jul 02, 2026, 5:13 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $56.51
Real-time Price: $46.50 info
Change: -$10.01 (-18%) info
Market Cap: $3.132B info
AXTI
Jul 02, 2026, 5:02 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $56.81
Real-time Price: $46.50 info
Change: -$10.31 (-18%) info
Market Cap: $3.132B info
AXTI
Jun 22, 2026, 4:08 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $92.96
Real-time Price: $46.50 info
Change: -$46.46 (-50%) info
Market Cap: $3.132B info
AXTI
Jun 17, 2026, 4:23 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $94.00
Real-time Price: $46.50 info
Change: -$47.50 (-51%) info
Market Cap: $3.132B info